Return to PJ Online Home Page
The Pharmaceutical Journal Vol 265 No 7121 p680
November 04, 2000 Letters

NHS pharmacy plan

Heads down

From Mr A. B. McCoig, MRPharmS

SIR,—Dr Goodyer and colleagues (PJ, October 28, p650) appear to be puzzled why your letters columns are not jammed with reactions from pharmacists on the latest document issued by the Government on the future of pharmacy. I welcome an opportunity to put forward some reasons why this debate may not warrant detailed comment at this time, at least from a community pharmacy viewpoint.
Let me reassure Dr Goodyer and colleagues that we have all read this document and are still considering the implications in their broadest sense. There have been initial guarded and qualified responses issued by our representative organisations, which have, on balance, tended to draw positive summaries. I would support these initial findings.
However, many community pharmacists may mirror my own feelings that, in one sense, we are hindered in being able to deliver the full range of services put forward by the Government because of the financial and traditional cul-de-sac we occupy. Historically, all financial commitments and investments have been entered into on the basis of carrying out the current contractual obligations under the National Health Service. For the overwhelming majority of pharmacists who are supported by bank loans and overdrafts, the continuation of the present dispensing service will be needed to keep the bailiffs from their doors unless a worthwhile alternative is put forward to replace the existing contract. The document indicates that a change is necessary in the way pharmacists are paid for existing and new pharmaceutical services but is deliberately vague about those items of service that will be “rewarded” and those that will be reduced. Broad hints are there for our interpretation but this part of the document conveys, on balance, the feeling that some form of imposition is likely to impact on the community pharmacist and this can only be translated as a threat. The recent statement made by Mr McKeon from the Department of Health reinforces this view (PJ, October 28, p638).
The other restriction many pharmacists will not be able to shake off easily is the internal design and layout of their pharmacies. When private consultation areas were first mentioned and considered desirable, some did actually start to make provision and floor space available in spite of the total absence of NHS funding for such a facility. I know of many that are underused or have now been turned over to other uses. At that time, it would appear that some community pharmacists “jumped the gun”, hoping that providing such an area would result in some sort of health authority funding, or at least compensation. Now it would appear that such an area would be recognised and considered to be necessary for providing more than the basic pharmaceutical services. Once more, we are left to wonder whether or not this item will be funded in some way or do we wait until we see the small print on the financial details? If we are to take on the role of medicines manager for many of our patients, and there are few who would argue against this, then we will need to sit down in the pharmacy and talk with them on a one-to-one basis. The same applies to other types of roles such as smoking cessation and health promotion in general. Again, there are no details about how our time and space will be funded other than the threat of stripping money from our colleagues who cannot provide such facilities.
Fundamentally, I see this document as recognising that which we should be doing without actually providing an adequate, fair structural and financial framework to achieve the aims and goals set out. The whole publication has been written almost as a wish list and if one considers the possibility that there may be another government at Westminster in the timeframe needed for implementation, then it is understandable why many community pharmacists are keeping their heads down. Until we are confident about new resources and the inevitable contractual obligations that will be attached, the visible fine line between “retail” and “practice” will remain blurred in community pharmacy.
I suspect that most community pharmacists will wait for further announcements from the DoH before they rip their pharmacies apart in preparation for the bright new future and engage in the debate requested.

Andrew McCoig
Secretary,
Croydon Local Pharmaceutical Committee, and
Chairman,
London LPC Forum